BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28604387)

  • 21. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
    Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
    J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas.
    Murakami M; Yoshimoto T; Nakabayashi K; Nakano Y; Fukaishi T; Tsuchiya K; Minami I; Bouchi R; Okamura K; Fujii Y; Hashimoto K; Hata KI; Kihara K; Ogawa Y
    Endocr Relat Cancer; 2017 Oct; 24(10):531-541. PubMed ID: 28747387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic
    Nanba K; Blinder AR; Rege J; Hattangady NG; Else T; Liu CJ; Tomlins SA; Vats P; Kumar-Sinha C; Giordano TJ; Rainey WE
    Hypertension; 2020 Mar; 75(3):645-649. PubMed ID: 31983310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
    Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
    Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
    Nanba K; Baker JE; Blinder AR; Bick NR; Liu CJ; Lim JS; Wachtel H; Cohen DL; Williams TA; Reincke M; Lyden ML; Bancos I; Young WF; Else T; Giordano TJ; Udager AM; Rainey WE
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2473-2482. PubMed ID: 35779252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
    Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
    J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Translationality of
    Kitamoto T; Nishikawa T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
    Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
    Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
    Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y
    Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
    Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations.
    Fernandes-Rosa FL; Amar L; Tissier F; Bertherat J; Meatchi T; Zennaro MC; Boulkroun S
    Mol Cell Endocrinol; 2015 Jun; 408():220-6. PubMed ID: 25617716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.